HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
93.0%
Total 13F principal
$361,263,910
Principal change
+$15,140,000
Total reported market value
$336,560,860
Number of holders
31
Value change
+$14,582,854
Number of buys
11
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q4 2017

As of 31 Dec 2017, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 31 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $361,263,910 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Linden Advisors LP, ADVENT CAPITAL MANAGEMENT /DE/, CANYON CAPITAL ADVISORS LLC, OAKTREE CAPITAL MANAGEMENT LP, SYMPHONY ASSET MANAGEMENT LLC, PRUDENTIAL PLC, Lion Point Capital, LP, STATE STREET CORP, and KINGDON CAPITAL MANAGEMENT, L.L.C.. This page lists 31 institutional bondholders reporting positions for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.